default author photo

Mark Lee

Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP)

New York, NY 10065

United States

SCHOLARLY PAPERS

1

DOWNLOADS

67

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictor of Survival and Response to Therapy in Patients Treated with Immune Checkpoint Inhibitors

Number of pages: 37 Posted: 23 Jul 2020
Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Information Systems, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Department of Epidemiology and Biostatistics and Memorial Sloan Kettering Cancer Center - Department of Surgery
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

Immune Checkpoint Inhibitors; Immunotherapy; Neutrophil-to-Lymphocyte Ratio; Biomarkers